Antigen Presentation by MHC Class II Molecules: Invariant Chain Function, Protein Trafficking, and the Molecular Basis of Diverse Determinant Capture
Human Immunology, ISSN: 0198-8859, Vol: 54, Issue: 2, Page: 159-169
1997
- 117Citations
- 78Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations117
- Citation Indexes117
- 117
- CrossRef98
- Captures78
- Readers78
- 78
Review Description
Major histocompatibility complex class II molecules are heterodimeric integral membrane proteins whose primary function is the presentation of antigenic peptides derived from proteins entering the endocytic pathway to CD4 + T lymphocytes. To accomplish this physiologic function, class II molecules must assemble in the secretory pathway without undergoing irreversible ligand association at that site, traffic efficiently to the endocytic pathway, and productively interact with protein ligands in these organelles before their ultimate expression on the plasma membrane. Here we review our work describing how invariant chain promotes the assembly and transport process, the complex itinerary of class II–invariant chain complexes through the endocytic pathway, the role of large protein fragments as substrates for class II binding, and the existence of a second pathway for antigen capture by mature class II molecules that complements that involving newly synthesized dimers. We integrate these observations into a coherent model for the operation of a class II-dependent antigen processing and presentation system able to capture diverse antigenic determinants present in proteins of varying structure.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0198885997000785; http://dx.doi.org/10.1016/s0198-8859(97)00078-5; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0030806054&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9297534; http://linkinghub.elsevier.com/retrieve/pii/S0198885997000785; http://api.elsevier.com/content/article/PII:S0198885997000785?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0198885997000785?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0198885997000785; http://dx.doi.org/10.1016/s0198-8859%2897%2900078-5; https://dx.doi.org/10.1016/s0198-8859%2897%2900078-5
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know